These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27614750)

  • 1. Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.
    Kumari A; Bahl C; Singh N; Behera D; Sharma S
    Mol Biol Rep; 2016 Dec; 43(12):1383-1394. PubMed ID: 27614750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival.
    Liu L; Wu C; Wang Y; Zhong R; Duan S; Wei S; Lin S; Zhang X; Tan W; Yu D; Nie S; Miao X; Lin D
    J Thorac Oncol; 2011 Nov; 6(11):1793-800. PubMed ID: 21841506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 Arg72Pro polymorphism predicts survival outcome in lung cancer patients in Indian population.
    Sreeja L; Syamala V; Raveendran PB; Santhi S; Madhavan J; Ankathil R
    Cancer Invest; 2008 Feb; 26(1):41-6. PubMed ID: 18181044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
    Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses.
    Pinheiro UB; Fraga CA; Mendes DC; Farias LC; Cardoso CM; Silveira CM; D'Angelo MF; Jones KM; Santos SH; de Paula AM; Guimarães AL
    Tumour Biol; 2015 Dec; 36(12):9259-65. PubMed ID: 26099726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Variants in the Wingless Antagonist Genes (
    Bahl C; Singh N; Behera D; Sharma S
    Cancer Biother Radiopharm; 2018 Dec; 33(10):466-477. PubMed ID: 30346805
    [No Abstract]   [Full Text] [Related]  

  • 7. XPC Polymorphism and Risk for Lung Cancer in North Indian Patients Treated with Platinum Based Chemotherapy and Its Association with Clinical Outcomes.
    Lawania S; Singh N; Behera D; Sharma S
    Pathol Oncol Res; 2018 Apr; 24(2):353-366. PubMed ID: 28540485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlations between genetic variations of glutathione synthetase gene and the response to platinum-based chemotherapy and prognosis of small cell lung cancer patients].
    Feng T; Li HM; Yuan P; Yu DK; Ma F; Tan WW; Du ZL; Yang J; Huang Y; Lin DX; Xu BH; Tan W
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):115-120. PubMed ID: 28219206
    [No Abstract]   [Full Text] [Related]  

  • 9. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
    Wang YC; Chen CY; Chen SK; Chang YY; Lin P
    Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer.
    Han JY; Lee GK; Jang DH; Lee SY; Lee JS
    Cancer; 2008 Aug; 113(4):799-807. PubMed ID: 18618574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
    Mo J; Luo M; Cui J; Zhou S
    Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India.
    Ihsan R; Devi TR; Yadav DS; Mishra AK; Sharma J; Zomawia E; Verma Y; Phukan R; Mahanta J; Kataki AC; Kapur S; Saxena S
    DNA Cell Biol; 2011 Mar; 30(3):163-71. PubMed ID: 21043833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between XRCC1 polymorphisms and survival in non-small-cell lung cancer patients treated with platinum-based chemotherapy.
    Yuan P; Liu L; Wu C; Zhong R; Yu D; Wu J; Xu Y; Nie S; Miao X; Sun Y; Xu B; Lin D
    Cancer Biol Ther; 2010 Nov; 10(9):854-9. PubMed ID: 20814250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects.
    Zhou C; Chen H; Wang A
    Tumour Biol; 2013 Oct; 34(5):2961-9. PubMed ID: 23715779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of CASP7 polymorphisms and survival of patients with non-small cell lung cancer with platinum-based chemotherapy treatment.
    Qian J; Gu S; Wu Q; Zhao X; Wu W; Gao Z; Zhang W; Tan X; Wang H; Wang J; Fan W; Chen H; Han B; Lu D; Wei Q; Jin L
    Chest; 2012 Sep; 142(3):680-689. PubMed ID: 22441531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of the responsiveness of advanced non-small cell lung cancer to platinum-based chemotherapy with p53 and p73 polymorphisms].
    Yuan P; Miao XP; Zhang XM; Wang ZH; Tan W; Zhang XR; Sun Y; Xu BH; Lin DX
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):107-10. PubMed ID: 16750013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
    Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
    Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population.
    Sobti RC; Kaur P; Kaur S; Janmeja AK; Jindal SK; Kishan J; Raimondi S
    DNA Cell Biol; 2009 Sep; 28(9):443-9. PubMed ID: 19558213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a p53 codon 72 gene polymorphism with environmental factors and risk of lung cancer: a case control study in Mizoram and Manipur, a high incidence region in North East India.
    Saikia BJ; Das M; Sharma SK; Sekhon GS; Zomawia E; Singh YM; Mahanta J; Phukan RK
    Asian Pac J Cancer Prev; 2014; 15(24):10653-8. PubMed ID: 25605155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck.
    Li F; Sturgis EM; Chen X; Zafereo ME; Wei Q; Li G
    Cancer; 2010 May; 116(10):2350-9. PubMed ID: 20225330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.